{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:45:51Z","timestamp":1793339151560,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1053\/j.ajkd.2019.01.026","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T01:08:48Z","timestamp":1553562528000},"page":"15-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":186,"title":["Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial"],"prefix":"10.1053","volume":"74","author":[{"given":"Li-Jun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-zi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Fang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Fei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai-Nan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Li","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Cheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"245","key":"10.1053\/j.ajkd.2019.01.026_bib1","first-page":"709","article-title":"The commonest glomerulonephritis in the world: IgA nephropathy","volume":"64","author":"D'Amico","year":"1987","journal-title":"Q\u00a0J Med"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.026_bib2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1440-1797.2007.00898.x","article-title":"Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China","volume":"13","author":"Lv","year":"2008","journal-title":"Nephrology (Carlton)"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.026_bib3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2215\/CJN.01990213","article-title":"Progression of IgA nephropathy under current therapy regimen in a Chinese population","volume":"9","author":"Li","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2019.01.026_bib4","first-page":"139","article-title":"KDIGO clinical practice guideline for glomerulonephritis","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"5","key":"10.1053\/j.ajkd.2019.01.026_bib5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2017.9362","article-title":"Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial","volume":"318","author":"Lv","year":"2017","journal-title":"JAMA"},{"issue":"23","key":"10.1053\/j.ajkd.2019.01.026_bib6","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","article-title":"Intensive supportive care plus immunosuppression in IgA nephropathy","volume":"373","author":"Rauen","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1053\/j.ajkd.2019.01.026_bib7","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1007\/s00467-014-2863-y","article-title":"Eculizumab treatment for rescue of renal function in IgA nephropathy","volume":"29","author":"Rosenblad","year":"2014","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2019.01.026_bib8","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1681\/ASN.2016060640","article-title":"A\u00a0randomized, controlled trial of rituximab in IgA nephropathy with proteinuria and renal dysfunction","volume":"28","author":"Lafayette","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"10084","key":"10.1053\/j.ajkd.2019.01.026_bib9","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0140-6736(17)30550-0","article-title":"Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial","volume":"389","author":"Fellstrom","year":"2017","journal-title":"Lancet"},{"issue":"7","key":"10.1053\/j.ajkd.2019.01.026_bib10","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s11255-017-1574-2","article-title":"Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy","volume":"49","author":"Gao","year":"2017","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.026_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000487330","article-title":"Effects of hydroxychloroquine on proteinuria in immunoglobulin A nephropathy","volume":"47","author":"Yang","year":"2018","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2019.01.026_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2019.01.026_bib13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1191\/0961203306lu2313oa","article-title":"Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis","volume":"15","author":"Kasitanon","year":"2006","journal-title":"Lupus"},{"issue":"5","key":"10.1053\/j.ajkd.2019.01.026_bib14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10067-014-2527-0","article-title":"Evolution of chronic kidney disease in patients with systemic lupus erythematosus over a long-period follow-up: a single-center inception cohort study","volume":"33","author":"Pokroy-Shapira","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1053\/j.ajkd.2019.01.026_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/RHU.0000000000000395","article-title":"Long-term outcome of lupus nephritis class II in Argentine patients: an open retrospective analysis","volume":"22","author":"Collado","year":"2016","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"2","key":"10.1053\/j.ajkd.2019.01.026_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1191\/0961203306lu2271oa","article-title":"Sustained remission of lupus nephritis","volume":"15","author":"Barber","year":"2006","journal-title":"Lupus"},{"issue":"8","key":"10.1053\/j.ajkd.2019.01.026_bib17","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1177\/0961203312437270","article-title":"Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort","volume":"21","author":"Willis","year":"2012","journal-title":"Lupus"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.026_bib18","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1186\/ar3895","article-title":"Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"14","author":"Sacre","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1053\/j.ajkd.2019.01.026_bib19","first-page":"55","article-title":"Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells","volume":"24","author":"van den Borne","year":"1997","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1053\/j.ajkd.2019.01.026_bib20","doi-asserted-by":"crossref","first-page":"766","DOI":"10.6061\/clinics\/2013(06)07","article-title":"Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients","volume":"68","author":"Silva","year":"2013","journal-title":"Clinics"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.026_bib21","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.intimp.2013.09.013","article-title":"Cellular and urinary microRNA alterations in NZB\/W mice with hydroxychloroquine or prednisone treatment","volume":"17","author":"Chafin","year":"2013","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1053\/j.ajkd.2019.01.026_bib22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000484955","article-title":"Chloroquine autophagic inhibition rebalances Th17\/Treg-mediated immunity and ameliorates systemic lupus erythematosus","volume":"44","author":"An","year":"2017","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"10.1053\/j.ajkd.2019.01.026_bib23","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/ar4451","article-title":"Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset","volume":"16","author":"Dominguez-Gutierrez","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1053\/j.ajkd.2019.01.026_bib24","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1182\/blood.V95.11.3460","article-title":"Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties","volume":"95","author":"Goldman","year":"2000","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.ajkd.2019.01.026_bib25","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00467-017-3699-z","article-title":"New insights into the pathogenesis of IgA nephropathy","volume":"33","author":"Yeo","year":"2018","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2019.01.026_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/08830185.2016.1276903","article-title":"Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases","volume":"36","author":"Samy","year":"2017","journal-title":"Int Rev Immunol"},{"issue":"12","key":"10.1053\/j.ajkd.2019.01.026_bib27","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1093\/ndt\/gfp441","article-title":"Immune complex formation in IgA nephropathy: a case of the 'right' antibodies in the 'wrong' place at the 'wrong' time?","volume":"24","author":"Barratt","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1053\/j.ajkd.2019.01.026_bib28","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1681\/ASN.2011050464","article-title":"The pathophysiology of IgA nephropathy","volume":"22","author":"Suzuki","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.026_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092673","article-title":"Acute pretreatment with chloroquine attenuates renal I\/R injury in rats","volume":"9","author":"Todorovic","year":"2014","journal-title":"Plos One"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.026_bib30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI1052","article-title":"Chloroquine stimulates nitric oxide synthesis in murine, porcine, and human endothelial cells","volume":"102","author":"Ghigo","year":"1998","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1053\/j.ajkd.2019.01.026_bib31","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/HYPERTENSIONAHA.114.03587","article-title":"Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus","volume":"64","author":"Gomez-Guzman","year":"2014","journal-title":"Hypertension"},{"issue":"12","key":"10.1053\/j.ajkd.2019.01.026_bib32","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1681\/ASN.2007050526","article-title":"Remission of proteinuria improves prognosis in IgA nephropathy","volume":"18","author":"Reich","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2019.01.026_bib33","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/ndt\/gfr527","article-title":"Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population","volume":"27","author":"Le","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2019.01.026_bib34","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.ajkd.2016.02.042","article-title":"Early change in urine protein as a surrogate end point in studies of IgA nephropathy: an individual-patient meta-analysis","volume":"68","author":"Inker","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2019.01.026_bib35","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1177\/0961203396005001031","article-title":"Anti-malarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development","volume":"5","author":"Fox","year":"1996","journal-title":"Lupus"},{"issue":"7","key":"10.1053\/j.ajkd.2019.01.026_bib36","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrneph.2017.67","article-title":"Glomerular disease: updated Oxford Classification of IgA nephropathy: a new MEST-C score","volume":"13","author":"Markowitz","year":"2017","journal-title":"Nat Rev Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638619301337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638619301337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:19:15Z","timestamp":1759461555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638619301337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0272638619301337"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2019.01.026","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2019.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}